These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1492 related articles for article (PubMed ID: 27999003)

  • 1. Diabetic Neuropathy: A Position Statement by the American Diabetes Association.
    Pop-Busui R; Boulton AJ; Feldman EL; Bril V; Freeman R; Malik RA; Sosenko JM; Ziegler D
    Diabetes Care; 2017 Jan; 40(1):136-154. PubMed ID: 27999003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetic neuropathy and diabetic foot syndrome (update 2023)].
    Köhler G; Eichner M; Abrahamian H; Kofler M; Sturm W; Menzel A
    Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):164-181. PubMed ID: 37101039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology.
    Diabetes Care; 1988; 11(7):592-7. PubMed ID: 3060328
    [No Abstract]   [Full Text] [Related]  

  • 4. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
    Handelsman Y; Henry RR; Bloomgarden ZT; Dagogo-Jack S; DeFronzo RA; Einhorn D; Ferrannini E; Fonseca VA; Garber AJ; Grunberger G; LeRoith D; Umpierrez GE; Weir MR
    Endocr Pract; 2016 Jun; 22(6):753-62. PubMed ID: 27082665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    J Am Coll Cardiol; 2009 Jan; 53(3):298-304. PubMed ID: 19147051
    [No Abstract]   [Full Text] [Related]  

  • 6. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    Diabetes Care; 2009 Jan; 32(1):187-92. PubMed ID: 19092168
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
    Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
    Circulation; 2009 Jan; 119(2):351-7. PubMed ID: 19095622
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for diabetic peripheral neuropathy in resource-limited settings.
    Nkonge KM; Nkonge DK; Nkonge TN
    Diabetol Metab Syndr; 2023 Mar; 15(1):55. PubMed ID: 36945043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic neuropathy and diabetic foot syndrome (Update 2019)].
    Lechleitner M; Abrahamian H; Francesconi C; Kofler M; Sturm W; Köhler G
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):141-150. PubMed ID: 30980143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.
    Solomon SD; Chew E; Duh EJ; Sobrin L; Sun JK; VanderBeek BL; Wykoff CC; Gardner TW
    Diabetes Care; 2017 Sep; 40(9):1285. PubMed ID: 28705833
    [No Abstract]   [Full Text] [Related]  

  • 11. Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412-418.
    Solomon SD; Chew E; Duh EJ; Sobrin L; Sun JK; VanderBeek BL; Wykoff CC; Gardner TW
    Diabetes Care; 2017 Jun; 40(6):809. PubMed ID: 28432087
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights from the 82
    Tentolouris A; Eleftheriadou I; Tentolouris N; Papanas N
    Int J Low Extrem Wounds; 2023 May; ():15347346231177569. PubMed ID: 37218173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic neuropathy].
    Lechleitner M; Francesconi M; Abrahamian H
    Acta Med Austriaca; 2004; 31(5):171-2. PubMed ID: 15747992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic neuropathy].
    Lechleitner M; Abrahamian H; Francesconi M
    Wien Klin Wochenschr; 2012 Dec; 124 Suppl 2():33-8. PubMed ID: 23250455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic neuropathy].
    Lechleitner M; Abrahamian H; Francesconi C; Kofler M
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S73-9. PubMed ID: 27052228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is New on Diabetic Neuropathy? Insights from the 2023 ADA and EASD Conferences.
    Rebelos E; Anastasiou IA; Tentolouris A; Papanas N; Jude E
    Int J Low Extrem Wounds; 2024 Feb; ():15347346241233938. PubMed ID: 38414376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes.
    Hicks CW; Selvin E
    Curr Diab Rep; 2019 Aug; 19(10):86. PubMed ID: 31456118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance.
    Fujimoto WY; Leonetti DL; Kinyoun JL; Shuman WP; Stolov WC; Wahl PW
    Diabetes; 1987 Jun; 36(6):730-9. PubMed ID: 3569672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic Retinopathy: A Position Statement by the American Diabetes Association.
    Solomon SD; Chew E; Duh EJ; Sobrin L; Sun JK; VanderBeek BL; Wykoff CC; Gardner TW
    Diabetes Care; 2017 Mar; 40(3):412-418. PubMed ID: 28223445
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS; ; ;
    Diabetes Care; 2010 Jun; 33(6):1395-402. PubMed ID: 20508233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 75.